How is the severity of valvular regurgitation classified based on regurgitant volume?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Severity Classification of Valvular Regurgitation Based on Regurgitant Volume

Valvular regurgitation severity is classified by regurgitant volume as: mild (<30 mL/beat), moderate (30-59 mL/beat), and severe (≥60 mL/beat) for aortic regurgitation, with similar thresholds applied to mitral regurgitation. 1

Standardized Severity Thresholds

The 2020 ACC/AHA Valvular Heart Disease Guidelines provide definitive cutoffs for aortic regurgitation severity based on regurgitant volume 1:

Mild Regurgitation:

  • Regurgitant volume: <30 mL/beat
  • Regurgitant fraction: <30%
  • Effective regurgitant orifice (ERO): <0.10 cm²

Moderate Regurgitation:

  • Regurgitant volume: 30-59 mL/beat
  • Regurgitant fraction: 30-49%
  • ERO: 0.10-0.29 cm²

Severe Regurgitation:

  • Regurgitant volume: ≥60 mL/beat
  • Regurgitant fraction: ≥50%
  • ERO: ≥0.3 cm²

Critical Clinical Considerations

These thresholds must be interpreted alongside other hemodynamic parameters, not in isolation. The guidelines emphasize that regurgitant volume interacts with multiple factors that affect clinical significance 2:

  • Driving velocity across the valve affects actual volume for a given orifice size
  • Duration of regurgitation (holosystolic vs. late systolic) substantially impacts total volume
  • Left ventricular size and function determine how a given regurgitant volume affects the patient—the same regurgitant volume may be disproportionately severe in a small ventricle or relatively well-tolerated in a dilated one

Measurement Methodology Pitfalls

A major caveat: regurgitant volume values differ significantly depending on measurement technique. Recent evidence demonstrates that PISA (proximal isovelocity surface area) methods and volumetric methods (echocardiographic or CMR-based) yield poorly correlated results 3:

  • PISA-derived regurgitant volume shows weak correlation with volumetric methods (r = 0.29-0.30)
  • Volumetric regurgitant volume correlates with LV size (r = 0.66-0.68), while PISA does not
  • This suggests volumetric methods are more physiologically accurate but are influenced by chamber size

Therefore, when using these thresholds, you must know which measurement method was used. The guideline thresholds are based on integrated multiparametric assessment, not a single measurement technique 1.

Practical Algorithm for Severity Assessment

  1. Measure regurgitant volume using quantitative methods (preferably volumetric: LV stroke volume minus aortic forward flow)
  2. Apply the thresholds above as initial classification
  3. Verify internal consistency by checking that regurgitant fraction and ERO align with the same severity grade
  4. Assess hemodynamic consequences: LV dilation, LV systolic dysfunction, left atrial enlargement, pulmonary pressures
  5. If measurements are discordant or conflict with clinical presentation, obtain TEE or cardiac MRI for definitive assessment 2

The regurgitant fraction (regurgitant volume/total LV stroke volume) may be more reliable than absolute regurgitant volume because it accounts for LV size and is less dependent on chamber dimensions 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.